Grifols DG-224 Blood Typing Centrifuge with Column Agglutination Technology

The Grifols DG-224 is a specialized blood typing centrifuge designed for clinical laboratories utilizing column agglutination technology (CAT). This system supports DG Gel cards featuring 8-column gel technology, essential for accurate blood group typing and antibody identification, widely adopted in molecular diagnostics and biotechnology workflows.

Key technical features include:

• Manual testing capability for both patient and donor blood typing, supporting a comprehensive assay menu.
• Capacity for up to 24 DG Gel cards, enabling high-throughput blood typing and antibody investigations in clinical and biopharmaceutical laboratory settings.
• Interchangeable DG spin head allows easy maintenance and adaptability to various testing protocols.
• Pre-programmed centrifugation parameters optimized for gel card processing at a consistent 990 rpm ±10 rpm speed, ensuring reliable and reproducible separation results.
• Digital display for real-time monitoring and an integrated alarm system to detect operational anomalies, promoting user safety and assay integrity.
• Built-in safety mechanisms include out-of-balance control and door-open detection, crucial for maintaining operational safety standards.

Technical specifications:

• Voltage range: 100-240 V compatible with international power standards.
• Frequency: 50-60 Hz for global laboratory deployment.
• Power consumption: 50 W max, supporting energy-efficient operation.
• Fuse requirements: 2 x T 2A L 250 V fuses.

The DG-224 centrifuge is critical in clinical blood group serology, supporting workflows in bioprocessing, molecular cloning diagnostics, and biomanufacturing environments where precise and reliable blood typing is essential. Its integration in synthetic biology and molecular biology research labs makes it a highly effective tool in biomedical engineering and clinical diagnostics applications.